Valuation CSPC Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. Other stock markets 04:08:24 2026-07-28 EDT			5-day change	1st Jan Change
8.490 ^HKD	+2.29%		-0.12%	+0.71%

07-24	CSPC Pharmaceutical Group Limited Announces Marketing Approval For Paliperidone Palmitate Injection	CI
07-22	CSPC Pharmaceutical Group Limited Initiates Phase II Clinical Trial of Sys6026 Injection for HPV Type 16 or 18 Related Cervical High Grade Squamous Intraepithelial Lesion in China	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	100,932	97,707	86,022	55,169	96,380	97,066	-	-
Change	-	-3.19%	-11.96%	-35.87%	74.7%	0.71%	-	-
Enterprise Value (EV) ¹	89,633	86,241	72,284	46,931	86,710	86,352	83,230	79,648
Change	-	-3.79%	-16.18%	-35.07%	84.76%	-0.41%	-3.62%	-4.3%
P/E	14.7x	14.1x	13.5x	12.1x	21.8x	11.8x	13.7x	12.6x
PBR	3.17x	2.86x	2.39x	1.62x	2.56x	2.26x	2.06x	1.88x
PEG	-	14.13x	-1.73x	-0.5x	-9.88x	0.1x	-1x	1.43x
Capitalization / Revenue	2.94x	2.77x	2.52x	1.78x	3.26x	2.72x	2.76x	2.59x
EV / Revenue	2.61x	2.44x	2.12x	1.51x	2.94x	2.42x	2.37x	2.12x
EV / EBITDA	9.5x	9.43x	8.39x	6.22x	12.1x	6.76x	8.38x	7.56x
EV / EBIT	10.7x	10.8x	9.77x	7.68x	15.6x	9.36x	10.8x	9.73x
EV / FCF	23.7x	14.1x	26.2x	17.5x	19.5x	11.7x	11.9x	8.5x
FCF Yield	4.22%	7.11%	3.82%	5.71%	5.12%	8.53%	8.39%	11.8%
Dividend per Share ²	0.18	0.21	0.28	0.26	0.29	0.3699	0.3697	0.3846
Rate of return	2.13%	2.56%	3.86%	5.44%	3.44%	4.36%	4.35%	4.53%
EPS ²	0.5773	0.5831	0.5376	0.3946	0.3859	0.7189	0.6181	0.6728
Distribution rate	31.2%	36%	52.1%	65.9%	75.2%	51.5%	59.8%	57.2%
Net sales ¹	34,309	35,292	34,175	31,046	29,533	35,695	35,174	37,539
EBITDA ¹	9,431	9,148	8,615	7,547	7,168	12,781	9,929	10,529
EBIT ¹	8,366	7,952	7,400	6,113	5,564	9,230	7,705	8,187
Net income ¹	6,901	6,949	6,382	4,632	4,409	7,935	6,932	7,547
Net Debt ¹	-11,298	-11,467	-13,738	-8,238	-9,670	-10,714	-13,837	-17,419
Reference price ²	8.470	8.200	7.260	4.780	8.430	8.490	8.490	8.490
Nbr of stocks (in thousands)	11,916,370	11,915,520	11,848,756	11,541,665	11,433,025	11,433,025	-	-
Announcement Date	3/22/22	3/22/23	3/20/24	3/28/25	3/25/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CSPC PHARMACEUTICAL GROUP LIMITED	11.65x	2.37x	6.69x	4.38%	12.1B
ELI LILLY AND COMPANY	35.56x	12.7x	26.67x	0.56%	1,068B
JOHNSON & JOHNSON	28.51x	6.52x	18.04x	2.02%	641B
ABBVIE INC.	32.33x	7.59x	15.6x	2.68%	454B
ROCHE HOLDING AG	19.49x	4.75x	11.79x	2.78%	351B
NOVARTIS AG	22.29x	5.76x	14.37x	2.78%	299B
ASTRAZENECA PLC	21.47x	4.5x	12.72x	1.93%	266B
NOVO NORDISK A/S	14.4x	5.35x	11.02x	3.48%	220B
AMGEN INC.	24.71x	6.49x	11.44x	2.68%	203B
GILEAD SCIENCES, INC.	-47.03x	5.64x	31.15x	2.53%	162B
Average	16.34x	6.17x	15.95x	2.58%	367.54B
Weighted average by Cap.	24.72x	7.95x	18.72x	1.96%